Company intelligence / Profile preview
i2o Therapeutics
Cambridge, Massachusetts, United Statesi2obio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
A biotech company developing oral peptide formulations and twice-yearly implants for chronic diseases, with multiple cardiometabolic assets in development including GLP-1 RAs and combination therapies.
- Therapeutic areas
- EndocrinologyCardiovascular
- Modalities
- PeptidesIonic liquid formulationsImplantable devices
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
JanssenSanofi
Beyond the preview
Go deeper on i2o Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on i2o Therapeutics.